Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. Through the controlled activation of progenitor cells, Frequency enables disease modification without the complexity of genetic engineering. Our lead program re-creates sensory cells in the inner ear to treat chronic noise induced hearing loss, which affects over 30 million people in the U.S. alone.

For more information, click here.

  • Frequency – MA
  • 300 Technology Square
  • 8th Floor
  • Cambridge, MA 02139
  • Frequency – CT
  • Cell and Genome Sciences building
  • 400 Farmington Ave
  • Farmington, CT 06032